AAAAAA

   
Results: 1-7 |
Results: 7
Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials
Authors: Atkins, MB Dutcher, J Weiss, G Margolin, K Clark, J Sosman, J Logan, T Aronson, F Mier, J
Citation: Mb. Atkins et al., Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part I.IL-2-based clinical trials, MED ONCOL, 18(3), 2001, pp. 197-207
Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part II: Management of IL-2 toxicity and studies with other cytokines
Authors: Dutcher, J Atkins, MB Margolin, K Weiss, G Clark, J Sosman, J Logan, T Aronson, F Mier, J
Citation: J. Dutcher et al., Kidney cancer: The Cytokine Working Group experience (1986-2001) - Part II: Management of IL-2 toxicity and studies with other cytokines, MED ONCOL, 18(3), 2001, pp. 209-219
A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-desk interleukin-2 in patients with renal cancer and melanoma
Authors: Atkins, HB Redman, B Mier, J Gollob, J Weber, J Sosman, J MacPherson, BL Plasse, T
Citation: Hb. Atkins et al., A phase I study of CNI-1493, an inhibitor of cytokine release, in combination with high-desk interleukin-2 in patients with renal cancer and melanoma, CLIN CANC R, 7(3), 2001, pp. 486-492
Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II cytokineworking group trials
Authors: Flaherty, LE Atkins, M Sosman, J Weiss, G Clark, JI Margolin, K Dutcher, J Gordon, MS Lotze, M Mier, J Sorokin, P Fisher, RI Appel, C Du, W
Citation: Le. Flaherty et al., Outpatient biochemotherapy with interleukin-2 and interferon alfa-2b in patients with metastatic malignant melanoma: Results of two phase II cytokineworking group trials, J CL ONCOL, 19(13), 2001, pp. 3194-3202
Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group study
Authors: Dutcher, JP Logan, T Gordon, M Sosman, J Weiss, G Margolin, K Plasse, T Mier, J Lotze, M Clark, J Atkins, M
Citation: Jp. Dutcher et al., Phase II trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: A Cytokine Working Group study, CLIN CANC R, 6(9), 2000, pp. 3442-3450
Organic hyperinsulinism and hypoglycemia due to coexistence of islet cell adenomatosis, nesidioblastosis, and hyperplasia in a patient with type 2 diabetes
Authors: Espinosa-de-los-Monteros, AL Mendoza, V Mier, J Cabrera, L Mercado, M
Citation: Al. Espinosa-de-los-monteros et al., Organic hyperinsulinism and hypoglycemia due to coexistence of islet cell adenomatosis, nesidioblastosis, and hyperplasia in a patient with type 2 diabetes, ENDOCRINOLO, 9(5), 1999, pp. 391-394
Early versus late necrosectomy for necrotizing pancreatitis - Reply
Authors: Mier, J
Citation: J. Mier, Early versus late necrosectomy for necrotizing pancreatitis - Reply, AM J SURG, 177(6), 1999, pp. 528-528
Risultati: 1-7 |